
{
  "Company Overview": {
    "Name": "Kronox Lab Sciences Ltd",
    "Sector": "Chemicals",
    "Industry": "Chemicals",
    "Business Description": "Manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals. KLSL is in High Purity Speciality Fine Chemicals Business with a portfolio of about 185 products including Excipients and ingredients, High Purity Reagents, Pharmaceutical, nutraceutical and Food Chemical.",
    "MarketPosition": "Part of BSE IPO" 
  },
  "Financial Metrics": {
    "Market Cap": "₹ 781 Cr.",
    "Current Price": "₹ 211",
    "High/Low": "₹ 229 / ₹ 138",
    "Stock P/E": 33.5,
    "Book Value": "₹ 20.8",
    "Dividend Yield": "0.24%",
    "ROCE": "51.5%",
    "ROE": "38.4%",
    "Face Value": "₹ 10.0",
    "DebtToEquityRatio": null //Not explicitly provided, needs further calculation from Balance Sheet data.
  },
  "Performance Trends": {
    "Quarterly Results": {
      "Sales": [21.47, 25.95, 21.02, 20.71, 22.18, 25.19, 24.86],
      "Expenses": [17.48, 17.43, 15.16, 14.40, 14.33, 16.98, 16.06],
      "Operating Profit": [3.99, 8.52, 5.86, 6.31, 7.85, 8.21, 8.80],
      "OPM %": ["18.58%", "32.83%", "27.88%", "30.47%", "35.39%", "32.59%", "35.40%"],
      "Other Income": [0.14, 0.24, 0.49, 0.42, 0.83, 0.43, 0.36],
      "Interest": [0.00, 0.00, 0.00, 0.00, 0.00, 0.00, 0.00],
      "Depreciation": [0.30, 0.32, 0.38, 0.30, 0.29, 0.33, 0.34],
      "Profit before tax": [3.83, 8.44, 5.97, 6.43, 8.39, 8.31, 8.82],
      "Tax %": ["36.55%", "24.53%", "27.14%", "24.57%", "29.92%", "25.99%", "26.64%"],
      "Net Profit": [2.44, 6.38, 4.35, 4.84, 5.88, 6.15, 6.47],
      "EPS in Rs": [0.66, 1.72, 1.17, 1.30, 1.58, 1.66, 1.74]
    },
    "Annual Results": {
      "Sales": [50, 62, 82, 96, 90, 93],
      "Expenses": [39, 48, 63, 74, 62, 62],
      "Operating Profit": [12, 15, 20, 22, 28, 31],
      "OPM %": ["23%", "24%", "24%", "23%", "32%", "34%"],
      "Other Income": [1, 1, 1, 2, 2, 2],
      "Interest": [0, 0, 0, 0, 0, 0],
      "Depreciation": [1, 2, 2, 2, 1, 1],
      "Profit before tax": [12, 13, 18, 22, 29, 32],
      "Tax %": ["27%", "26%", "26%", "26%", "25%"],
      "Net Profit": [9, 10, 14, 16, 21, 23],
      "EPS in Rs": [343.60, 403.73, 565.56, 4.42, 5.75, 6.28]
    },
    "Compounded Growth": {
      "Sales Growth": {
        "10 Years": null,
        "5 Years": null,
        "3 Years": "13%",
        "TTM": "-6%"
      },
      "Profit Growth": {
        "10 Years": null,
        "5 Years": null,
        "3 Years": "30%",
        "TTM": "30%"
      },
      "Stock Price CAGR": {
        "10 Years": null,
        "5 Years": null,
        "3 Years": null,
        "1 Year": null
      }
    },
    "Return on Equity": {
      "10 Years": null,
      "5 Years": null,
      "3 Years": "39%",
      "Last Year": "38%"
    }
  },
  "Ratios": {
    "Debtor Days": [110, 90, 114, 71, 72],
    "Inventory Days": [70, 58, 58, 61, 74],
    "Days Payable": [102, 69, 89, 52, 50],
    "Cash Conversion Cycle": [78, 79, 84, 80, 96],
    "Working Capital Days": [100, 100, 128, 83, 143],
    "ROCE %": ["50%", "51%", "50%", "52%"]
  },
  "Peer Comparison": {
    "Peers": [
      {"Name": "Pidilite Inds.", "CMP": 2976.80, "P/E": 77.17, "Mar Cap": 151413.76, "Div Yld": 0.54, "NP Qtr": 540.30, "Qtr Profit Var": 18.75, "Sales Qtr": 3234.91, "Qtr Sales Var": 5.16, "ROCE": 29.74},
      {"Name": "SRF", "CMP": 2277.60, "P/E": 59.78, "Mar Cap": 67513.72, "Div Yld": 0.32, "NP Qtr": 201.42, "Qtr Profit Var": -33.03, "Sales Qtr": 3424.30, "Qtr Sales Var": 7.77, "ROCE": 12.71},
      {"Name": "Linde India", "CMP": 6359.80, "P/E": 123.99, "Mar Cap": 54236.37, "Div Yld": 0.06, "NP Qtr": 104.39, "Qtr Profit Var": -2.17, "Sales Qtr": 634.42, "Qtr Sales Var": -10.81, "ROCE": 17.36},
      {"Name": "Gujarat Fluoroch", "CMP": 4329.05, "P/E": 115.96, "Mar Cap": 47554.61, "Div Yld": 0.07, "NP Qtr": 121.00, "Qtr Profit Var": 128.30, "Sales Qtr": 1188.00, "Qtr Sales Var": 25.45, "ROCE": 9.76},
      {"Name": "Godrej Industrie", "CMP": 1119.90, "P/E": 54.56, "Mar Cap": 37712.87, "Div Yld": 0.00, "NP Qtr": 488.86, "Qtr Profit Var": 229.46, "Sales Qtr": 4804.96, "Qtr Sales Var": 22.03, "ROCE": 5.59},
      {"Name": "Deepak Nitrite", "CMP": 2596.85, "P/E": 44.57, "Mar Cap": 35419.23, "Div Yld": 0.29, "NP Qtr": 194.20, "Qtr Profit Var": -5.31, "Sales Qtr": 2032.00, "Qtr Sales Var": 14.28, "ROCE": 21.65},
      {"Name": "Himadri Special", "CMP": 546.85, "P/E": 56.02, "Mar Cap": 26996.96, "Div Yld": 0.09, "NP Qtr": 135.70, "Qtr Profit Var": 34.53, "Sales Qtr": 1136.92, "Qtr Sales Var": 13.18, "ROCE": 18.81}
    ],
    "Median": {
      "CMP": 456.5,
      "P/E": 34.96,
      "Mar Cap": 1547.37,
      "Div Yld": 0.29,
      "NP Qtr": 9.66,
      "Qtr Profit Var": 6.63,
      "Sales Qtr": 168.44,
      "Qtr Sales Var": 6.18,
      "ROCE": 14.5
    }
  },
  "Other Insights": {
    "Pros": "Company is almost debt free. Company has a good return on equity (ROE) track record: 3 Years ROE 39.0%",
    "Cons": "Stock is trading at 10.1 times its book value",
    "Disclaimer": "The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.",
    "Shareholding Pattern Notes": "* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards. Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes. Click on the line-items to see the names of individual entities."
  },
  "BalanceSheet": {
    "Equity Capital": [0.25, 0.24, 0.24, 37, 37, 37],
    "Reserves": [23, 27, 40, 8, 29, 40],
    "Borrowings": [0, 4, 3, 0, 0, 0],
    "Other Liabilities": [11, 7, 13, 9, 8, 8],
    "Total Liabilities": [34, 38, 57, 54, 74, 85],
    "Fixed Assets": [6, 9, 11, 16, 26, 26],
    "CWIP": [0, 0, 0, 0, 0, 2],
    "Investments": [0, 0, 0, 0, 0, 0],
    "Other Assets": [29, 28, 45, 38, 47, 57],
    "Total Assets": [34, 38, 57, 54, 74, 85]
  },
  "CashFlow": {
    "Cash from Operating Activity": [4, 11, 9, 20, 17],
    "Cash from Investing Activity": [-4, -3, -8, -7, -17],
    "Cash from Financing Activity": [0, -7, -1, -13, 0],
    "Net Cash Flow": [0, 1, 1, 0, 0]
  },
  "ShareholdingPattern": {
    "Quarterly": {
      "Jun 2024": {
        "Promoters": "74.21%",
        "FIIs": "1.56%",
        "DIIs": "4.34%",
        "Public": "19.89%",
        "No. of Shareholders": 32604
      },
      "Sep 2024": {
        "Promoters": "74.21%",
        "FIIs": "0.56%",
        "DIIs": "2.57%",
        "Public": "22.66%",
        "No. of Shareholders": 39792
      }
    },
    "Yearly": {
      "Promoters": "74.21%",
      "FIIs": [1.56, 0.56],
      "DIIs": [4.34, 2.57],
      "Public": [19.89, 22.66]
    }
  },
  "Documents": [
    {"Title": "UPDATE ON DEVELOPMENT STATUS OF UNIT-IV", "Date": "13 Nov", "Description": "Received approvals for construction of Unit-IV at Dahej."},
    {"Title": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "Date": "13 Nov", "Description": "Newspaper publication of unaudited financial results."},
    {"Title": "Financial Results For The Quarter And Half Year Ended 30Th September, 2024", "Date": "12 Nov", "Description": null},
    {"Title": "Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th November, 2024", "Date": "12 Nov", "Description": "Board approved standalone unaudited financial results."},
    {"Title": "Board Meeting Intimation for Considering The Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30, 2024", "Date": "30 Oct", "Description": "Board meeting scheduled to approve financial results."}
  ]
}
